Search results

  1. D

    Notice about a forthcoming paper: A Proposed Mechanism for ME/CFS Invoking Macrophage Fc-gamma-RI and Interferon Gamma

    What bank holiday? Over here, Monday is Memorial Day--considered the start of the summer season.
  2. D

    Patients with severe ME/CFS need hope and expert multidisciplinary care, 2025, Miller et al

    "Activist" is not considered a dirty or insultng word in the U.S. I only consider it insulting myself if it is meant that way, as it always is when used by these people. The term "campaigner," used in an equially insulting way in the UK as "activist," from my perception, is not used at all in...
  3. D

    Patients with severe ME/CFS need hope and expert multidisciplinary care, 2025, Miller et al

    https://virology.ws/2025/05/21/trial-by-error-bmj-publishes-new-propaganda-piece-on-severe-me-cfs/
  4. D

    Patients with severe ME/CFS need hope and expert multidisciplinary care, 2025, Miller et al

    No. Long Covid has really changed the equation. Many/most of the signers got into this issue because of that.
  5. D

    Patients with severe ME/CFS need hope and expert multidisciplinary care, 2025, Miller et al

    Why wouldn't he be??? Doesn't he state these views on every platform??
  6. D

    Patients with severe ME/CFS need hope and expert multidisciplinary care, 2025, Miller et al

    This is my gut feeling as well. I think it's very helpful to counter these things when they appear and post rapid responses and so on, but it's also important not presume that this one or the next one will really impact this ongoing struggle. Responding to each incident with maximal outrage...
  7. D

    Trial Report Cost Utility of Specialist Physiotherapy for Functional Motor Disorder (Physio4FMD), 2025, Hunter, Stone, Carson, Edwards et al

    They've also rejected my request for a correction: Hello Dr. Tuller, Thank you for your concern regarding this article. We appreciate you taking the time to reach out and share your thoughts. Please know that our Editor-in-Chief, as well as the Editor of Neurology Clinical Practice, have both...
  8. D

    Trial Report Cost Utility of Specialist Physiotherapy for Functional Motor Disorder (Physio4FMD), 2025, Hunter, Stone, Carson, Edwards et al

    Yes, but they used that non-statistically significant difference of .03 to calculate the cost-effectiveness
  9. D

    Brief Outpatient Rehabilitation Program for Post-COVID-19 Condition, Nerli et al, 2024 - with comment from T. Chalder

    https://virology.ws/2025/05/15/trial-by-error-pushback-on-brief-outpatient-rehab-trial-for-long-covid-from-norwegian-ideological-brigades/
  10. D

    Trial Report Cost Utility of Specialist Physiotherapy for Functional Motor Disorder (Physio4FMD), 2025, Hunter, Stone, Carson, Edwards et al

    yes. If you throw everything at them, they can answer something and ignore key points. This way, there’s only one point.
  11. D

    Trial Report Cost Utility of Specialist Physiotherapy for Functional Motor Disorder (Physio4FMD), 2025, Hunter, Stone, Carson, Edwards et al

    Not often. But it's worth letting them know someone is paying attention. I find best to focus on just one point that's a definite error rather than going on about the various other questions about the paper.
  12. D

    Trial Report Cost Utility of Specialist Physiotherapy for Functional Motor Disorder (Physio4FMD), 2025, Hunter, Stone, Carson, Edwards et al

    https://virology.ws/2025/05/13/trial-by-error-a-letter-seeking-a-correction-in-fmd-physiotherapy-paper/
  13. D

    Trial Report Cost Utility of Specialist Physiotherapy for Functional Motor Disorder (Physio4FMD), 2025, Hunter, Stone, Carson, Edwards et al

    https://virology.ws/2025/05/12/trial-by-error-when-primary-outcomes-yield-null-results-in-clinical-trials-fnd-experts-prefer-their-secondary-outcomes/
  14. D

    Trial Report Cost Utility of Specialist Physiotherapy for Functional Motor Disorder (Physio4FMD), 2025, Hunter, Stone, Carson, Edwards et al

    The cost-effectiveness article tried to explain why the CGI-I scale is better than SF-36 as a primary outcome. They say this: "The secondary outcome, the patient-reported Clinical Global Impression Improvement score, allows for a broader assessment of potential impacts that specialist...
  15. D

    Australia: National Health and Medical Research Council (NHMRC): Development of ME/CFS guidelines

    https://virology.ws/2025/05/09/trial-by-error-australian-gps-keep-promoting-exercise-treatments-for-me-cfs/
Back
Top Bottom